Delivery Order SPE2DB20D3101-SPE2DB24FRST3

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $56,290.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 1,000 units of the prescription medication Venlafaxine HCL ER 75 mg capsules. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.86 firm fixed-price delivery order is for the supply of Venlafaxine HCL ER 75 mg capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
This federal contract award (SPE2DB20D1100|SPE2DB25FY54C) was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566110668 Venlafaxine HCL ER 75 MG Capsules in quantities of 90s. The contract has a ceiling value of $1,018.40 and is a firm fixed price delivery order contract, with an ultimate completion date of October 16, 2024. This contract is not associated with any set-aside program. Amerisourcebergen Drug Corp's...
This federal contract award, with ID SPE2DX15D3109|SPE2DX24FXVTM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,728.39 firm fixed-price delivery order is for the supply of 1,000 units of the medication Venlafaxine HCl ER 75 mg capsules. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Venlafaxine HCL ER 37.5 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,585.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 23, 2024. The contract has a completion date of February 26, 2024 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor for this award and does not have any listed...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,900.32 delivery order contract is for the supply of Venlafaxine HCL ER 37.5 mg capsules, a medication used to treat depression and anxiety. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. Amerisourcebergen, headquartered in Conshohocken, Pennsylvania, is the...
The federal contract award is for the delivery of venlafaxine hydrochloride extended-release 75mg tablets in 30-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $1,295.78 contract is a delivery order without a set-aside designation, awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition support to the U.S. Armed...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.53, is for the supply of 4566625013 - Venlafaxine HCL ER 37.5 MG Capsules, 90-count, with a period of performance through December 6, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a larger $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562647857 VENLAFAXINE HCL ER 37.5 MG CAP 90S, a generic prescription medication. The contract is a Delivery Order with a Firm Fixed Price of $1,368.45 and an ultimate completion date of October 31, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $1,939.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,144 units of Venlafaxine HCL ER 75 mg capsules, a prescription medication used to treat mental health conditions. The award has an ultimate completion date of December 20, 2023 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRST3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.50 firm-fixed-price delivery order is for the supply of venlafaxine hydrochloride extended-release 75 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 2/27/25, 10:01 AM